BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32847475)

  • 1. Longitudinal study of cognitive function in glioma patients treated with modern radiotherapy techniques and standard chemotherapy.
    Rydelius A; Lätt J; Kinhult S; Engelholm S; Van Westen D; Pihlsgård M; Bengzon J; Sundgren PC; Lilja Å
    Acta Oncol; 2020 Sep; 59(9):1091-1097. PubMed ID: 32847475
    [No Abstract]   [Full Text] [Related]  

  • 2. Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings.
    Hilverda K; Bosma I; Heimans JJ; Postma TJ; Peter Vandertop W; Slotman BJ; Buter J; Reijneveld JC; Klein M
    J Neurooncol; 2010 Mar; 97(1):89-94. PubMed ID: 19718545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective longitudinal evaluation of cognition and depression in postoperative patients with high-grade glioma following radiotherapy and chemotherapy.
    Wang Q; Qi F; Song X; Di J; Zhang L; Zhou Y; Lu X; Chang J; Yu Y
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S1048-S1051. PubMed ID: 30539844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma.
    Taylor BV; Buckner JC; Cascino TL; O'Fallon JR; Schaefer PL; Dinapoli RP; Schomberg P
    J Clin Oncol; 1998 Jun; 16(6):2195-201. PubMed ID: 9626221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy versus radiotherapy combined with temozolomide in high-risk low-grade gliomas after surgery: study protocol for a randomized controlled clinical trial.
    Wang J; Wang Y; He Y; Guan H; He L; Mu X; Peng X
    Trials; 2019 Nov; 20(1):641. PubMed ID: 31752981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study.
    Froklage FE; Oosterbaan LJ; Sizoo EM; de Groot M; Bosma I; Sanchez E; Douw L; Heimans JJ; Reijneveld JC; Lagerwaard FJ; Buter J; Uitdehaag BM; Klein M; Postma TJ
    J Neurooncol; 2014 Jan; 116(2):387-94. PubMed ID: 24264531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.
    Douw L; Klein M; Fagel SS; van den Heuvel J; Taphoorn MJ; Aaronson NK; Postma TJ; Vandertop WP; Mooij JJ; Boerman RH; Beute GN; Sluimer JD; Slotman BJ; Reijneveld JC; Heimans JJ
    Lancet Neurol; 2009 Sep; 8(9):810-8. PubMed ID: 19665931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidomain and long-term cognitive evaluation in malignant glioma patients.
    Tanzilli A; Pace A; Prosperini L; Oppido PA; Telera S; Rasile F; Farneti A; Marucci L; Villani V
    Future Oncol; 2022 May; 18(15):1839-1848. PubMed ID: 35196869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficacy of stereotactic radiation therapy combined with temozolomide on recurrent brain glioma].
    Zhao H; Liu S; Jiang C; Li X; Tang S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 43(4):394-397. PubMed ID: 29774875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EpiBrainRad: an epidemiologic study of the neurotoxicity induced by radiotherapy in high grade glioma patients.
    Durand T; Jacob S; Lebouil L; Douzane H; Lestaevel P; Rahimian A; Psimaras D; Feuvret L; Leclercq D; Brochet B; Tamarat R; Milliat F; Benderitter M; Vayatis N; Noël G; Hoang-Xuan K; Delattre JY; Ricard D; Bernier MO
    BMC Neurol; 2015 Dec; 15():261. PubMed ID: 26684198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of temozolomide on gonadal function in patients with primary malignant brain tumors.
    Strowd RE; Blackwood R; Brown M; Harmon M; Lovato J; Yalcinkaya T; Lesser G
    J Oncol Pharm Pract; 2013 Dec; 19(4):321-7. PubMed ID: 23292971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
    Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M
    J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.
    Perry JR; Bélanger K; Mason WP; Fulton D; Kavan P; Easaw J; Shields C; Kirby S; Macdonald DR; Eisenstat DD; Thiessen B; Forsyth P; Pouliot JF
    J Clin Oncol; 2010 Apr; 28(12):2051-7. PubMed ID: 20308655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role?
    Wen PY
    J Clin Oncol; 2010 Apr; 28(12):1977-9. PubMed ID: 20308652
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.
    Stupp R; Hegi ME; Neyns B; Goldbrunner R; Schlegel U; Clement PM; Grabenbauer GG; Ochsenbein AF; Simon M; Dietrich PY; Pietsch T; Hicking C; Tonn JC; Diserens AC; Pica A; Hermisson M; Krueger S; Picard M; Weller M
    J Clin Oncol; 2010 Jun; 28(16):2712-8. PubMed ID: 20439646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen : Acute toxicity in pediatric high-grade glioma patients.
    Seidel C; von Bueren AO; Bojko S; Hoffmann M; Pietsch T; Gielen GH; Warmuth-Metz M; Bison B; Kortmann RD; Kramm CM
    Strahlenther Onkol; 2018 Mar; 194(3):215-224. PubMed ID: 29022050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial.
    Gehring K; Sitskoorn MM; Gundy CM; Sikkes SA; Klein M; Postma TJ; van den Bent MJ; Beute GN; Enting RH; Kappelle AC; Boogerd W; Veninga T; Twijnstra A; Boerman DH; Taphoorn MJ; Aaronson NK
    J Clin Oncol; 2009 Aug; 27(22):3712-22. PubMed ID: 19470928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant Transformation of Molecularly Classified Adult Low-Grade Glioma.
    Tom MC; Park DYJ; Yang K; Leyrer CM; Wei W; Jia X; Varra V; Yu JS; Chao ST; Balagamwala EH; Suh JH; Vogelbaum MA; Barnett GH; Prayson RA; Stevens GHJ; Peereboom DM; Ahluwalia MS; Murphy ES
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1106-1112. PubMed ID: 31461674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study.
    Abete-Fornara G; Bintintan Socaciu P; Fanizzi C; Fiore G; Locatelli M; Caroli M
    J Neurooncol; 2023 Dec; 165(3):561-568. PubMed ID: 38108984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.